14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $18.88 $18.88 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $18.88 $18.88
52 weeks $8.39 $19.12

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
Aug 09, 2017 $9.75 $10.15 $9.50 $9.65 1 388 777
Aug 08, 2017 $9.40 $9.60 $9.15 $9.20 1 105 166
Aug 07, 2017 $9.45 $9.70 $9.30 $9.45 822 365
Aug 04, 2017 $10.00 $10.00 $9.40 $9.45 2 275 451
Aug 03, 2017 $10.35 $10.55 $9.90 $9.90 1 596 780
Aug 02, 2017 $10.50 $10.60 $10.25 $10.40 761 591
Aug 01, 2017 $10.75 $10.75 $10.30 $10.50 1 449 351
Jul 31, 2017 $10.95 $11.05 $10.65 $10.75 708 204
Jul 28, 2017 $10.55 $11.25 $10.55 $10.90 940 401
Jul 27, 2017 $11.30 $11.30 $10.50 $10.65 1 198 855
Jul 26, 2017 $11.50 $11.50 $11.15 $11.20 1 138 159
Jul 25, 2017 $11.85 $11.95 $11.20 $11.45 1 941 317
Jul 24, 2017 $11.50 $11.90 $11.20 $11.90 1 211 477
Jul 21, 2017 $11.95 $12.00 $11.50 $11.50 1 584 851
Jul 20, 2017 $12.00 $12.02 $11.65 $11.85 957 194
Jul 19, 2017 $11.85 $12.15 $11.65 $12.00 2 956 672
Jul 18, 2017 $11.75 $12.05 $11.15 $11.55 1 653 457
Jul 17, 2017 $11.60 $12.15 $11.55 $11.85 1 501 813
Jul 14, 2017 $12.15 $12.80 $11.20 $11.65 3 939 020
Jul 13, 2017 $10.55 $12.20 $10.50 $11.95 15 870 198
Jul 12, 2017 $10.85 $11.00 $10.05 $10.13 5 112 995
Jul 11, 2017 $11.70 $12.30 $11.65 $12.20 984 237
Jul 10, 2017 $11.85 $12.00 $11.50 $11.80 604 238
Jul 07, 2017 $11.95 $12.12 $11.65 $11.85 926 253
Jul 06, 2017 $11.70 $12.00 $11.50 $11.95 1 816 002
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT